Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07786428

Tailored Neoadjuvant Chemoimmunotherapy for Stage I TNBC

Conditions: Triple-Negative Breast Cancer (TNBC)

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: PHASE2

Enrollment: 60

Sponsor: University of Texas Southwestern Medical Center

Location: University of Texas Southwestern Medical Center Dallas Texas

Summary

The goal of this clinical trial is to compare the effectiveness of several treatment regimens for stage I triple negative breast cancer before surgery. The main question it aims to answer is if these regimens will reduce or completely remove all cancer cells before surgery.

Eligibility Criteria

Inclusion Criteria: * Must have histologically confirmed invasive triple negative breast cancer as defined by ER/PR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07786428). StuddyBuddy aggregates publicly available trial information.